Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,660,300 papers from all fields of science
Search
Sign In
Create Free Account
camonagrel
Known as:
5-(2-imidazol-1-ylethoxy)-1-indancarboxylic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Indans
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Pharmacokinetics of Camonagrel in experimental animal: rat, rabbit and dog
C. Albet
,
J. A. A. Pérez
,
E. Rozman
,
A. Sacristan
,
J. Ortiz
European Journal of Drug Metabolism and…
2010
Corpus ID: 21206300
Camonagrel is a novel selective thromboxane synthetase inhibitor. The aim of this study was to determine its main pharmacokinetic…
Expand
2003
2003
Effects of Camonagrel, a Selective Inhibitor of Platelet Thromboxane Synthase, on the Platelet-Subendothelium Interaction
M. A. Villalobos
,
J. P. De La Cruz
,
R. Escalante
,
M. Arrebola
,
A. Guerrero
,
F. Sánchez de la Cuesta
Pharmacology
2003
Corpus ID: 45737365
The aim of this study was to compare the effects of a new thromboxane synthase inhibitor, camonagrel, on platelet aggregation and…
Expand
2002
2002
Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1.
S. Chlopicki
,
J. Bartuś
,
R. Gryglewski
Polish journal of pharmacology
2002
Corpus ID: 16331575
Recent evidence suggests that hypoxic pulmonary vasoconstriction (HPV) is mediated by hypoxia-induced closure of voltage-gated…
Expand
1999
1999
Biphasic response to lipopolysaccharide from E. coli in the isolated ventilated blood-perfused rat lung.
S. Chlopicki
,
J. Bartuś
,
R. Gryglewski
Journal of physiology and pharmacology : an…
1999
Corpus ID: 2794248
We characterised early circulatory and respiratory responses to lipopolysaccharide from E. coli (LPS, serotype 0127:B8) in the…
Expand
1999
1999
Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
J. Bochenski
,
S. Chlopicki
,
R. Gryglewski
Journal of physiology and pharmacology : an…
1999
Corpus ID: 22833463
The mechanism of early pulmonary and systemic haemodynamic response to intravenous infusion of LPS from Escherichia coli was…
Expand
1998
1998
Protective role of pulmonary nitric oxide in the acute phase of endotoxemia in rats.
R. Gryglewski
,
P. Wołkow
,
+6 authors
T. Malinski
Circulation research
1998
Corpus ID: 17938189
We present for the first time direct continuous assay of NO concentration (porphyrinic sensor) in the lung parenchyma of Sprague…
Expand
1998
1998
Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes.
J. P. De La Cruz
,
A. Moreno
,
M. Ruiz-Ruiz
,
J. G. García Campos
,
F. Sánchez de la Cuesta
European journal of pharmacology
1998
Corpus ID: 28534644
1996
1996
The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats.
R. Korbut
,
R. Gryglewski
Journal of physiology and pharmacology : an…
1996
Corpus ID: 34156732
Six hours after administration of E. Coli endotoxin (LPS) into rats (10 mg kg-1, i.p.) a significant (P < 0.001) decline in the…
Expand
1996
1996
A paradox of thrombogenesis by streptokinase and its prevention by iloprost and camonagrel.
R. Korbut
,
R. Gryglewski
Methods and findings in experimental and clinical…
1996
Corpus ID: 44811392
Here we report that streptokinase is responsible for forming thrombi both in vitro on blood-superfused endothelial cells of…
Expand
1995
1995
The mechanism of anti-thrombotic, thrombolytic and fibrinolytic actions of camonagrel--a new thromboxane synthase inhibitor.
R. Gryglewski
,
A. Szczeklik
,
+4 authors
P. Maga
Wiener klinische Wochenschrift
1995
Corpus ID: 25489277
So far pharmacological consequences of inhibition of thromboxane A2 (TXA2) synthase by imidazole derivatives (e.g., camonagrel or…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE